BioSpecifics to merge with Endo in $540M deal
October 19, 2020
WILMINGTON – BioSpecifics Technologies Corp. announced Monday morning that it has entered into a merger deal with pharmaceutical giant Endo International PLC worth $540 million. As a small commercial-stage biopharmaceutical […]
chat_bubble0 Comment
visibility1743 Views
Premier Digital Partners
© 2024 Delaware Business Times
